Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PLASMA Trial: Phospholipase Levels And Serological Markers of Atherosclerosis: A Dose-Response Clinical Pharmacology Study of A-002 In Subjects With Stable Coronary Artery Disease

NCT00455546 is registered in ClinicalTrials.gov with Anthera Pharmaceuticals as lead sponsor.

NCT NCT00455546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00455546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PLASMA Trial: Phospholipase Levels And Serological Markers of Atherosclerosis: A Dose-Response Clinical Pharmacology Study of A-002 In Subjects With Stable Coronary Artery Disease
Lead sponsor
Anthera Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2007
Completion date
September 30, 2007
Enrollment
400 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad)